Squarepoint
MIRM icon

Squarepoint’s Mirum Pharmaceuticals MIRM Stock Holding History

Squarepoint’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.7M Sell
61,692
-110,734
-64% -$10.4M 0.01% 1403
2025
Q4 		$13.6M Buy
172,426
+44,523
+35% +$3.2M 0.01% 933
2025
Q3 		$9.38M Buy
127,903
+109,626
+600% +$6.97M 0.01% 1105
2025
Q2 		$930K Sell
18,277
-16,185
-47% -$721K ﹤0.01% 2726
2025
Q1 		$1.55M Buy
34,462
+12,780
+59% +$602K ﹤0.01% 2296
2024
Q4 		$897K Buy
+21,682
New +$904K ﹤0.01% 3162
2024
Q3 		– Sell
-67,421
Closed -$2.31M – 4472
2024
Q2 		$2.31M Buy
67,421
+26,154
+63% +$686K ﹤0.01% 1946
2024
Q1 		$1.04M Sell
41,267
-90,945
-69% -$2.5M ﹤0.01% 2565
2023
Q4 		$3.9M Buy
132,212
+32,555
+33% +$985K 0.01% 1551
2023
Q3 		$3.15M Buy
99,657
+62,398
+167% +$1.71M 0.01% 1488
2023
Q2 		$964K Buy
+37,259
New +$991K ﹤0.01% 2185
2023
Q1 		– Sell
-15,117
Closed -$295K – 3560
2022
Q4 		$295K Buy
+15,117
New +$299K ﹤0.01% 2589
2021
Q1 		– Sell
-21,441
Closed -$374K – 3425
2020
Q4 		$374K Sell
21,441
-2,220
-9% -$43.6K ﹤0.01% 2045
2020
Q3 		$456K Sell
23,661
-4,326
-15% -$92.8K 0.01% 1504
2020
Q2 		$545K Sell
27,987
-6,879
-20% -$115K 0.01% 1271
2020
Q1 		$488K Buy
+34,866
New +$572K 0.01% 1057

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Squarepoint's MIRM Position: Q1 2026 in Review

Squarepoint reduced its Mirum Pharmaceuticals (MIRM) stake by 64% in Q1 2026, selling an estimated $10.4M and leaving 61,692 shares worth $5.7M. The position accounts for 0.01% of the portfolio, ranked #1403.

Squarepoint first reported a position in MIRM in Q1 2020 and has held it in 16 quarters since. The position peaked at $13.6M in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Squarepoint held 61,692 shares of Mirum Pharmaceuticals worth $5.7M as of Q1 2026.
  • Squarepoint sold 110,734 Mirum Pharmaceuticals shares in Q1 2026, an estimated $10.4M.
  • Mirum Pharmaceuticals made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1403 holding.
  • Squarepoint first reported a position in Mirum Pharmaceuticals in Q1 2020 and has held it in 16 quarters since.
  • Squarepoint's Mirum Pharmaceuticals position peaked at $13.6M in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.